Compass Pathways Plc (CMPS)
11.90
-0.05
(-0.42%)
USD |
NASDAQ |
Oct 02, 16:00
11.91
+0.01
(+0.08%)
After-Hours: 20:00
Compass Pathways Net Income (Quarterly) : -254.25M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -254.25M |
| March 31, 2026 | 77.50M |
| December 31, 2025 | -93.74M |
| September 30, 2025 | -136.86M |
| June 30, 2025 | -38.88M |
| March 31, 2025 | -17.93M |
| December 31, 2024 | -42.93M |
| September 30, 2024 | -38.90M |
| June 30, 2024 | -38.14M |
| March 31, 2024 | -35.17M |
| December 31, 2023 | -32.82M |
| September 30, 2023 | -33.20M |
| June 30, 2023 | -28.43M |
| Date | Value |
|---|---|
| March 31, 2023 | -24.43M |
| December 31, 2022 | -31.16M |
| September 30, 2022 | -18.21M |
| June 30, 2022 | -20.85M |
| March 31, 2022 | -21.05M |
| December 31, 2021 | -25.68M |
| September 30, 2021 | -15.78M |
| June 30, 2021 | -17.49M |
| March 31, 2021 | -12.76M |
| December 31, 2020 | -18.81M |
| September 30, 2020 | -16.69M |
| June 30, 2020 | -16.25M |
| March 31, 2020 | -8.590M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Silence Therapeutics Plc | -12.27M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -4.134M |
| Mereo BioPharma Group Plc | -7.018M |
| HemoGenyx Pharmaceuticals Plc | -- |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 254.25M |
| EPS Diluted (Quarterly) | -1.883 |
| Enterprise Value | 1.236B |
| Earnings Yield | -38.86% |
| Normalized Earnings Yield | -27.18 |